Jan 06, 2026
Arrowhead Obesity Drugs Show Significant Fat Loss In Early Human Trials

, Inc. (NASDAQ:ARWR) on Tuesday shared interim results from two Phase 1/2a trials of ARO-INHBE and ARO-ALK7, the company’s investigational RNA interference (RNAi) therapeutics for obesity. Preliminary results showed meaningful reductions in multiple key measures, including visceral fat, total fat,…

Jan 06, 2026
As Venezuela Reopens, Peter Schiff Says Gold Is The Real Story

While markets are fixated on Venezuela's oil reopening, a quieter — and potentially far more explosive — asset sits in the background: gold. Venezuela holds roughly 161 metric tons of gold, noted The Kobeissi Letter on X, making it Latin…

Jan 06, 2026
Palantir Technologies Options Trading: A Deep Dive into Market Sentiment

Financial giants have made a conspicuous bearish move on Palantir Technologies. Our analysis of options history for Palantir Technologies (NASDAQ:PLTR) revealed 12 unusual trades. Delving into the details, we found 25% of traders were bullish, while 66% showed bearish tendencies.…

Jan 06, 2026
Trump Media, TAE Begin Hunt For Fusion Plant Site

Trump Media & Technology Group Corp. (NASDAQ:DJT) and TAE Technologies are taking early steps toward commercial fusion power in the U.S., even as investors remain divided on the company’s long-term outlook. Fusion Plant Planning Begins Ahead Of 2026 Build The…

Jan 06, 2026
Evaluating Tesla Against Peers In Automobiles Industry

Amidst today's fast-paced and highly competitive business environment, it is crucial for investors and industry enthusiasts to conduct comprehensive company evaluations. In this article, we will delve into an extensive industry comparison, evaluating Tesla (NASDAQ:TSLA) in comparison to its major…

Jan 06, 2026
A Look Into Colgate-Palmolive Inc’s Price Over Earnings

In the current session, Colgate-Palmolive Inc. (NYSE:CL) is trading at $76.78, after a 0.19% drop. Over the past month, the stock fell by 0.26%, and in the past year, by 12.21%. With performance like this, long-term shareholders are more likely…